Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Regeneron Pharmaceuticals, Inc. (NQ: REGN)
250.31 USD  -4.56 (-1.79%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about Regeneron Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 Next >
Six Biotech Stocks Riding the Baby Boomer Wave
June 06, 2012
The size and scope of the Baby Boom generation has opened up an abundance of health care opportunities --especially ground-breaking and game-changing biotech stocks. As this "gray wave" matures the... Read More
category biotech stocks to watch , biotech stocks 2011 , biotech stock market , and 4 more.
from Money Morning
Market Forecast + Sector Watch: SPX, Nasdaq, XLF, FDN, BTK, GLD, GS, GOOG, PCLN, EXPE, ARBA, AMZN, SOHU, REGN, MDVN, VRTX, BIIB, GILD, AMGN
April 30, 2012
Last weekend, in my Market Forecast, I wrote: "For the new week, we may get a slow start.  AAPL’s earnings on Tuesday after market could be one of the deciding events this week.  If the market were to... Read More
category REGN , AMZN , GLD , and 15 more.
from Wang's Happy Trading
Eylea Drives Regeneron To Profit
April 27, 2012
Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) first quarter 2012 earnings (excluding special items but including stock-based compensation) of 15 cents per share compared favorably with the Zacks... Read More
category REGN , SNY , Stocks , and 3 more.
from DailyMarkets.com
Eylea Drives Regeneron To Profit
April 27, 2012
Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) first quarter 2012 earnings (excluding special items but including stock-based compensation) of 15 cents per share compared favorably with the Zacks... Read More
category REGN , SNY , Stocks , and 3 more.
from DailyMarkets.com
Up/Downgrades: PTEN, ZMH, REGN, CTCT, KOG, QGEN, UGI, STX, ZNGA, NIHD
April 27, 2012
New York, April 27th (TradersHuddle.com) - Research Calls ahead of the market open. Patterson-UTI ( NASDAQ:PTEN ) was downgraded to Underperform from Market Perform at BMO Capital. Zimmer Ho. Read More... Read More
from TradersHuddle.com
Amazon (AMZN) Rivals AAPL Earnings With Its Own Blowout! SPX, Nasdaq, REGN, CRUS, EQIX, AMZN, EXPE, PCLN, SWKS, WDC, FIO, DECK
April 26, 2012
Strong earnings continued to keep the market afloat.  The market has been on a 2-day run after AAPL’s blowout earnings on Tuesday after the market.  Last night, CRUS reported a strong quarter, sending... Read More
category SWKS , REGN , AMZN , and 8 more.
from Wang's Happy Trading
MarkMarket Forecast + Sector Watch: SPX, Nasdaq, XLF, XME, SOXX, BTK, CLF, BTU, WLT, AA, FCX, ALTR, SNDK, BRCM, TXN, REGN, GILD, HGSI, ILMN, ALXN, CELG, AMLN
April 23, 2012
In my Market Forecast last week, I said, "For the new week, we may see the market take a deeper drop to start out the week.  SPX has support between 1360 and 1340, while the support for Nasdaq lies... Read More
category REGN , XLF , Uncategorized , and 18 more.
from Wang's Happy Trading
Biotech Laggard
April 18, 2012
Whether one attributes it to good news on the FDA front or increased mergers and acquisitions speculation, the biotech space has been a solid performer this year. The same goes for the major ETFs that... Read More
from TradersHuddle.com
Priority Review For Zaltrap
April 05, 2012
Recently, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and partner Sanofi (NYSE:SNY) announced that their oncology candidate Zaltrap (aflibercept) will be reviewed on a priority basis by the US Food... Read More
category REGN , SNY , Stocks , and 2 more.
from DailyMarkets.com
Still Neutral On Ardea Biosciences
April 04, 2012
We are maintaining our Neutral recommendation on Ardea Biosciences Inc. (NASDAQ:RDEA) with a target price of $23.00. Ardea Biosciences, headquartered in San Diego, California, focuses on the discovery... Read More
category SVNT , REGN , RDEA , and 4 more.
from DailyMarkets.com
Biotechs Breaking Out! SPX, Nasdaq, FFIV, CMG, MA, LULU, AAPL, PCLN, BIIB, REGN, CELG, VRTX, MDVN
April 03, 2012
Well, things once again are moving along as discussed in my Market Forecast this weekend.  On Monday, the market popped higher and pushed above the recent resistance levels.  But, today, financials did... Read More
category CMG , REGN , MA , and 9 more.
from Wang's Happy Trading
New Ratings ( REGN, CERE, XPO )
April 02, 2012
New York, April 2nd (TradersHuddle.com) - Pre-market new initiations and ratings. Regeneron Pharmaceuticals ( NASDAQ:REGN ) was initiated with a Buy at Goldman Sachs. Ceres (<a href="http://. Read More... Read More
from TradersHuddle.com
Market Forecast + Sector Watch: SPX, Nasdaq, USO, XLE, OIH, XME, IGV, XLF, BTU, PCX, CLF, WLT, X, STLD, CRM, VMW, FFIV, CTSH, CTXS, CHKP, WFC, JPM, GS, BLK, MA, V, CELG, GILD, ALXN, REGN
April 02, 2012
Last weekend, in my Market Forecast, we discussed, "For the new week, it seems this market just does not want to go down.  Techs still appear strong.  Nasdaq has resistance between 3090 and 3100.  SPX... Read More
category XLE , REGN , VMW , and 26 more.
from Wang's Happy Trading
Pipeline Progress At Regeneron
March 29, 2012
Recently, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and partner Sanofi (NYSE:SNY) announced encouraging data from two mid-stage studies which evaluated their candidate SAR236553/REGN727 for reducing... Read More
category REGN , SNY , Stocks , and 4 more.
from DailyMarkets.com
Encouraging Data On Amgen Candidate
March 27, 2012
Amgen (NASDAQ:AMGN) recently presented positive data on its hypercholesterolemia candidate, AMG145. Results were presented at the American College of Cardiology Scientific Session from a phase Ib study... Read More
category ALNY , REGN , AMGN , and 3 more.
from DailyMarkets.com
Australian Clearance For Eye-Drug Eylea
March 09, 2012
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and the HealthCare unit of Bayer (BAYRY) announced recently that their eye-drug Eylea has been cleared by the Australian Therapeutic Goods Administration... Read More
category NVS , REGN , Stocks , and 3 more.
from DailyMarkets.com
Regeneron Treads The Neutral Path
February 22, 2012
We continue to have a Neutral recommendation on Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) following the appraisal of fourth quarter and full-year 2011 results. Regeneron suffered a wider... Read More
category NVS , REGN , JPM , and 4 more.
from DailyMarkets.com
Regeneron’s Loss Widens, Eylea Grows
February 15, 2012
Regeneron Pharmaceuticals Inc.’s (NASDAQ:REGN) fourth quarter 2011 net loss (excluding special items but including stock-based compensation) of 54 cents per share was narrower than the Zacks Consensus... Read More
category REGN , SNY , JPM , and 4 more.
from DailyMarkets.com
It's a New Bull Market, Baby
February 14, 2012
Why what's happening right now in the biotechnology sector is an eye-opener. Read More
from Wealth Daily
Indices Close Ahead on Good Technicals
February 13, 2012
The week started off with a bang as the stock market indices gapped up big time, but then pulled back sharply to do retesting at about 2555 on the Nasdaq 100 and 1346 on the S&P 500. That held, and... Read More
from Harry's Hotline by Harry Boxer
Up/Downgrades ( TEN, MSFT, REGN, KAR, BAC, SPLS, PG, DHI, CPRT )
January 30, 2012
New York, January 30th (TradersHuddle.com) - Research Calls ahead of the market open. Tenneco ( NYSE:TEN ) was upgraded to Outperform from Market Perform at Wells Fargo. Microsoft (<a href="h. Read... Read More
from TradersHuddle.com
REGN Projects Strong Q4 Eylea Sales
January 13, 2012
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced at the global healthcare conference of JPMorgan (NYSE:JPM) that its eye drug Eylea is off to a strong start in the US. Regeneron announced at the... Read More
category REGN , JPM , Stocks , and 3 more.
from DailyMarkets.com
Top Biotech Movers (CRL, REGN, ARNA, TNGN)
January 10, 2012
New York, January 10th (TradersHuddle.com) - Charles River Laboratories ( NYSE: CRL ) jumped 17.30% to $32.47 after it announced that it would present at the J.P. Morgan 30th Annual Healthcare... Read More
from TradersHuddle.com
Biotechs Lead the Market Higher: REGN, MDVN, VERTX, CELG, GILD, GS, FAS, LULU, FSLR, NOV, EOG, BIDU, SOHU, SINA, TIF, CF, AGU, MON, MOS, POT
January 10, 2012
In my Market Forecast this weekend, I highlighted the recent bulliness of the biotech sector.  During the past two days, biotechs have led the market higher.  MDVN went up +10.9% in the past two days;... Read More
category NOV , MON , REGN , and 18 more.
from Wang's Happy Trading
Market Forecast + Sector Watch: SPX, Nasdaq, GLD, XME, XLF, BTK, MA, V, GS, JPM, WFC, BAC, REGN, DNDN, MDVN, BIIB, VRTX, HGSI, BTU, CLF, CAT, JOY, WLT
January 09, 2012
Ok, that was a nice first week of the year!  But, let’s not get ahead of ourselves.  Media likes to report statistics.  It goes something like this:  in the past __ years, when ________ happens, __% of... Read More
category REGN , GLD , XLF , and 19 more.
from Wang's Happy Trading
Another (Near) Perfect Week! NFLX, GS, UPS, DNDN, MDVN, REGN, BIIB
January 07, 2012
The market had a pretty good week.  But, all of the gains were pretty much made on the first trading day of the year when good economic news from Europe and Asia boosted markets globally. ... Read More
category REGN , GS , Uncategorized , and 5 more.
from Wang's Happy Trading
Top Biotech Movers (VICL, BDSI, TNGN, DNDN, REGN)
January 06, 2012
New York, January 6th (TradersHuddle.com) – Vical Incorporated ( NASDAQ: VICL ) plunged 12.15% to $3.76 in the morning trading after the company announced the pricing of an underwritten public offering... Read More
from TradersHuddle.com
Upgrades: AMTG, CERN, CPNO, XIDE, FST, HVT, IVR, PDC, REN, REGN, VOD
January 06, 2012
New York, January 6th (TradersHuddle.com) – Following are some of the upgrades and before the market open. Apollo Residential Mortgage ( NASDAQ:AMTG . Read More -- Read More
from TradersHuddle.com
Regeneron Settles Dispute
January 04, 2012
Recently, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reached a non-exclusive license and partial settlement agreement with Genentech, Inc. {a wholly owned subsidiary of Roche (RHHBY)} regarding the... Read More
category NVS , RHHBY , REGN , and 3 more.
from DailyMarkets.com
Regeneron’s Eylea Data Unimpressive
December 07, 2011
Recently, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and partner Bayer (BAYRY) presented not very encouraging two-year data from a couple of parallel late-stage studies (VIEW 1 and VIEW 2) of their... Read More
category NVS , REGN , Stocks , and 3 more.
from DailyMarkets.com
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here